![Heidi Henson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heidi Henson
Directeur/Membre du Conseil chez
PERSPECTIVE THERAPEUTICS, INC.
Fortune : 281 966 $ au 31/05/2026
Profil
Heidi Henson currently works at Cend Therapeutics, Inc., as Director from 2019, Lisata Therapeutics, Inc., as Independent Director from 2022, Perspective Therapeutics, Inc., as Independent Director from 2023, PepGen Inc., as Independent Non-Executive Director from 2021, and The Association of Bioscience Financial Officers, as Member.
Ms. Henson also formerly worked at Anadys Pharmaceuticals, Inc., as Director-Finance, Fair Isaac Corp., as Principal, La Jolla Pharmaceutical Co., as Controller from 2004 to 2005, HNC Software, Inc., as Principal, PricewaterhouseCoopers LLP, as Auditor, Zeta Acquisition Corp.
III, as Chief Financial Officer & Secretary, Araxes Pharma LLC, as Chief Financial Officer & Secretary from 2012 to 2018, Kura Oncology, Inc., as Secretary, Chief Financial & Accounting Officer from 2014 to 2018, Intellikine LLC, as Vice President-Finance from 2011 to 2012, Wellspring Biosciences LLC, as Chief Financial Officer & Secretary from 2012 to 2018, Imbria Pharmaceuticals, Inc., as Chief Financial Officer from 2019 to 2020, Respivant Sciences, Inc., as Chief Financial Officer from 2018 to 2019, Pardes Biosciences, Inc., as Chief Financial Officer from 2021 to 2023, and San Diego Children's Choir, as Chief Financial Officer.
Ms. Henson received her undergraduate degree from the University of San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/01/2026 | 55 269 ( 0,61% ) | 179 624 $ | 31/05/2026 | |
| 02/04/2026 | 25 975 ( 0,02% ) | 102 342 $ | 31/05/2026 | |
PEPGEN INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Heidi Henson
| Sociétés | Poste | Début |
|---|---|---|
| PEPGEN INC. | Directeur/Membre du Conseil | 01/07/2021 |
| LISATA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/09/2022 |
| PERSPECTIVE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2023 |
Cend Therapeutics, Inc.
 Cend Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company that provides treatment for tumor cancers | Directeur/Membre du Conseil | 31/01/2019 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Corporate Officer/Principal | - |
Anciens postes connus de Heidi Henson
| Sociétés | Poste | Fin |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Directeur Financier/CFO | 30/08/2023 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Directeur Financier/CFO | 01/07/2020 |
Respivant Sciences, Inc.
 Respivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for patients with respiratory diseases | Directeur Financier/CFO | 01/04/2019 |
Araxes Pharma LLC
 Araxes Pharma LLC Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and other diseases | Directeur Financier/CFO | 01/07/2018 |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Heidi Henson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
38
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Fair Isaac Corp.
 Fair Isaac Corp. Financial Publishing/ServicesCommercial Services Provides business-to-business and consumer scoring & software services | Commercial Services |
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
HNC Software, Inc.
 HNC Software, Inc. Packaged SoftwareTechnology Services Provides software solutions | Technology Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Zeta Acquisition Corp. III
 Zeta Acquisition Corp. III MiscellaneousMiscellaneous Operates as a blank check company | Miscellaneous |
Araxes Pharma LLC
Araxes Pharma LLC Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and other diseases | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
San Diego Children's Choir
 San Diego Children's Choir San Diego Children's Choir is a nonprofit choral training organization serving children ages 3 to 18 across multiple locations. The choir performs locally and on tours, collaborates with the San Diego Symphony, and participates in festivals and notable venues. The non-profit company is based in San Diego, CA. It provides music education and performance opportunities through programs such as an early childhood prelude program and sequential ensemble choirs for grades 1-12, with auditioned choirs starting in grade 4. Weekly rehearsals use creative methods like Orff and Kodaly, focusing on music literacy and healthy vocal technique, and are supported by professional musicians. Enrollment occurs twice yearly, with free auditions via Zoom, and tuition varies by choir level, including rehearsals, performances, and materials. Need-based scholarships and tuition-free instruction are available to over 70% of students, especially through outreach programs in underserved Title 1 schools, often in partnership with the Diamond Educational Excellence Partnership (DEEP). The organization relies on donations, grants, and fundraising for operational costs and scholarships, and encourages community involvement through volunteering, attending performances, and financial support. | |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
Wellspring Biosciences LLC
 Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases | Health Technology |
Cend Therapeutics, Inc.
Cend Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company that provides treatment for tumor cancers | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Respivant Sciences, Inc.
Respivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for patients with respiratory diseases | Health Technology |
PepGen Inc.
 PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Lisata Therapeutics, Inc.
 Lisata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Perspective Therapeutics, Inc.
 Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
